Pillstats
Rx only · Injection, Powder, For Solution · Intramuscular

Olanzapine

Brands: Zyprexa Intramuscular · Olanzapine

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)61381
US makers9 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$6.85$13.69$20.54$27.38Sep 2025Apr 2026Jul 2026
$21.895
Latest avg · Jul 22, 2026
-8%
Since Sep 17, 2025
9
Active US suppliers
30%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.4K2.7K4.1K5.5K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.3K
Rx · 2026 Q1
8.1K
Units dispensed
-30%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sandoz Incunknown2SUPPLYING
UBI Pharma Inc.unknown1SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING
Qilu Pharmaceutical Co. Ltd.unknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
PAI Holdings, LLC dba PAI Pharmaunknown1SUPPLYING
XGen Pharmaceuticals DJB, Inc.unknown1SUPPLYING
NorthStar RxLLCunknown1SUPPLYING
H2-Pharma, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.